https://www.selleckchem.com/pr....oducts/idf-11774.htm
BACKGROUND Status epilepticus (SE) is an emergent neurologic condition that carries a high risk of morbidity and mortality. Intravenous brivaracetam (IV BRV) may be an alternative anticonvulsant against status epilepticus, although the sparseness of controlled studies on the topic limits its recommendation for this indication. OBJECTIVES This systematic review aimed to determine the efficacy and safety of IV BRV in the treatment of status epilepticus. METHODS A comprehensive literature search was conducted until December 2019 through